A fast ultra-performance liquid chromatography method for simultaneous quantification of mycophenolic acid and its phenol- and acyl-glucuronides in human plasma

Therapeutic Drug Monitoring

Volumn 31, Issue 1, 2009, Pages 110-115

  Musuamba, Flora Tshinanu ^a   Di Fazio, Vincent ^b   Vanbinst, Roger ^a   Wallemacq, Pierre ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

AcMPAG; MPA; MPAG; Therapeutic drug monitoring; UPLC

Indexed keywords

ACYL GLUCURONIDE; DRUG METABOLITE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYL GLUCURONIDE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; HUMAN; KIDNEY ALLOGRAFT REJECTION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS;

ANTIBIOTICS, ANTINEOPLASTIC; BIOTRANSFORMATION; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCURONIDES; HUMANS; MYCOPHENOLIC ACID; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 60449113843     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318191897d     Document Type: Article

References (35)

1. Shipkova M, Armstrong VW, Oellerich M, et al. Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability. Expert Opin Drug Metab Toxicol. 2005;1:505-526.
2. Langman LJ, LeGatt DF, Yatscoff RW. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measuring IMP dehydrogenase activity. Clin Chem. 1995;41:295-299.
3. Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet. 1998;34:429-455.
4. Schütz E, Shipkova M, Armstrong VW, et al. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Clin Chem. 1999;45:419-422.
5. Shipkova M, Armstrong VW, Weber L, et al. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients. Ther Drug Monit. 2002;24:390-399.
6. Hale MD, Nicholls AJ, Bullingham RES, et al. The pharmacokinetic- pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther. 1998;64:672-683.
7. van Gelder T, Hilbrands LB, Vanrenterghem Y, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation. 1999;68:261-266.
8. van Gelder T, Le Meur Y, Shaw LM, et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit. 2006;28:145-154.
9. Oellerich M, Armstrong VW. The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments. Ther Drug Monit. 2006;28:720-725.
10. Brandhorst G, Streit F, Goetze S, et al. Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites. Clin Chem. 2006;52:1962-1964.
11. Shipkova M, Schutz E, Armstrong VW, et al. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. Clin Chem. 2000;46:365-372.
12. Premaud A, Rousseau A, Le Meur Y, et al. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Ther Drug Monit. 2004;26:609-619.
13. Khoschsorur G, Erwa W. Liquid chromatography method for simultaneous determination of mycophenolic acid and its phenol and acyl glucuronide metabolites in plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;799:355-360.
14. Westley IS, Sallustio BC, Morris RG. Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolite in human plasma. Clin Biochem. 2005;38: 824-829.
15. Brandhorst G, Streit F, Goetze S, et al. Quantification of mycophenolic acid by an optimized LC-MS/MS method compared to a new IMPDH inhibition assay on the cobas c 501 analyzer. Clin Chem. 2007;53(Suppl): B-137.
16. Mino Y, Naito T, Matsushita T, et al. Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography. J Pharm Biomed. 2008;46:603-608.
17. Patel CG, Akhlaghi F. High performance liquid chromatography method for determination of mycophenolic acid and its acyl and phenol glucuronide in human plasma. Ther Drug Monit. 2006;28:116-122.
18. Patel CG, Mendonza AE, Akhlaghi F, et al. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;813:287-294.
19. Ohyama K, Kishikawa N, Nakagawa H, et al. Simultaneous determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human serum by capillary zone electrophoresis. J Pharm Biomed. 2008; 64:201-206.
20. Nguyen DT, Guillaume D, Rudaz S, et al. Fast analysis in liquid chromatography using small particles size and ultra high pressure. J Sep Sci. 2006;129:836-848.
21. Center for Drug Evaluation and Research, Food and Drug Administration. Bioanalytical Method Validation. Guidance for Industry 2001. Available at: http://www.fda.gov/cder/guidance/4252fnl.htm. Accessed April 2008.
22. Analytical Services International. Available at: http://www.bioanalytics. co.uk/. Accessed April 2008.
23. Yau WP, Vathsala A, Lou HX, et al. Simple reverse phase ion-pair liquid chromatography for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;805:101-112.
24. Aresta A, Palmisano F, Zambonin CG, et al. Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mofetil therapy by ion-pair reverse phase liquid chromatography with diode array UV-detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;810:197-202.
25. Watson DG, Araya FG, Galloway PJ, et al. Development of a high performance liquid chromatography method for determination of mycophenolic acid and its glucuronide metabolite in small volumes of plasma from paediatric patients. J Pharm Biomed Anal. 2004;35:87-92.
26. de Loor H, Naesens M, Verbeke K. Stability of mycophenolic acid in plasma and impact of deproteinization methodology. Clin Chim Acta. 2008;389:87-92.
27. Atcheson B, Taylor PJ, Mudge DW, et al. Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid chromatography using mass spectrometric and ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;799:157-167.
28. Bolon M, JeanPierre L, El Barkil M, et al. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material. J Pharm Biomed Anal. 2004;36:649-651.
29. Hobotsubo H, Takahara S, Kokado Y, et al. Rapid and simultaneous determination of mycophenolic acid and its glucuronide conjugate in human plasma by ion-pair reverse phase high performance liquid chromatography using isocratic elution. J Chromatogr B Biomed Sci Appl. 2001;753:315-320.
30. Bahrami G, Mohammadi B. An isocratic high performance liquid chromatography method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: application to human PK studies. Clin Chim Acta. 2006;370:185-190.
31. Indjova D, Kassabova L, Svinarov D. Simultaneous determination of MPA and its phenolic glucuronide in human plasma using isocratic high performance liquid chromatography procedure. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;817:327-330.
32. Knox JH, Saleem M. Kinetic conditions for optimum speed and resolution in column chromatography. J Chromatogr Sci. 1969;7:614-622.
33. Knox JH. Practical aspects of LC theory. J Chromatogr Sci. 1977;15:352-364.
34. Guillaume D, Nguyen DT, Rudaz S, et al. Method transfer for fast liquid chromatography in pharmaceutical analysis: application to short columns packed with small particles - Part I: isocratic separation. Eur J Pharm Biopharm. 2007;66:475-482.
35. Mandla R, Line PD, Midtvedt K, et al. Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients. Ther Drug Monit. 2003;25:407-414.